185 related articles for article (PubMed ID: 25400773)
1. Associations between Cox-2 rs20417 and rs5275 polymorphisms and the risk of hepatocellular carcinoma: a meta analysis.
Wu H; Wu X; Wan G; Zhang S
Int J Clin Exp Pathol; 2014; 7(10):6898-905. PubMed ID: 25400773
[TBL] [Abstract][Full Text] [Related]
2. Cyclooxygenase-2 gene polymorphisms and susceptibility to hepatocellular carcinoma: A meta-analysis based on 10 case-control studies.
Xu W; Huang Y; Zhang T; Zhao L; Fan J; Li L
J Cancer Res Ther; 2018; 14(Supplement):S105-S113. PubMed ID: 29578159
[TBL] [Abstract][Full Text] [Related]
3. Association of interleukin-6 gene polymorphisms with the risk of hepatocellular carcinoma: An up-to-date meta-analysis.
An PP; Feng LN; Zhang XX; Jin QL
Medicine (Baltimore); 2020 Dec; 99(50):e23659. PubMed ID: 33327352
[TBL] [Abstract][Full Text] [Related]
4. Association between rs20417 polymorphism in cyclooxygenase-2 and gastric cancer susceptibility: Evidence from15 case-control studies.
Chen S; Chen L; Tan Y; Wang J
Medicine (Baltimore); 2019 May; 98(18):e15468. PubMed ID: 31045826
[TBL] [Abstract][Full Text] [Related]
5. Association between hepatocellular carcinoma and tumor necrosis factor alpha polymorphisms in South Korea.
Shin SP; Kim NK; Kim JH; Lee JH; Kim JO; Cho SH; Park H; Kim MN; Rim KS; Hwang SG
World J Gastroenterol; 2015 Dec; 21(46):13064-72. PubMed ID: 26672513
[TBL] [Abstract][Full Text] [Related]
6. Association between PNPLA3 rs738409 polymorphisms and risk of hepatocellular carcinoma and its development in patients with cirrhosis: a meta-analysis.
Zhang S; Wu H; Wu X; Lian W; Wang Y; Zhang X; Peng X
Int J Clin Exp Med; 2015; 8(5):6638-49. PubMed ID: 26221201
[TBL] [Abstract][Full Text] [Related]
7. Functional polymorphisms of cyclooxygenase-2 gene and risk for hepatocellular carcinoma.
Akkız H; Bayram S; Bekar A; Akgöllü E; Ülger Y
Mol Cell Biochem; 2011 Jan; 347(1-2):201-8. PubMed ID: 21042835
[TBL] [Abstract][Full Text] [Related]
8. The association between three cyclooxygenase-2 polymorphisms and hepatocellular carcinoma risk: a meta-analysis.
Chen Z; Zhu J; Huang C; Lian F; Wu G; Zhao Y
PLoS One; 2015; 10(3):e0118251. PubMed ID: 25730260
[TBL] [Abstract][Full Text] [Related]
9. PIK3CA polymorphisms associated with susceptibility to hepatocellular carcinoma.
Li HG; Liu FF; Zhu HQ; Zhou X; Lu J; Chang H; Hu JH
Int J Clin Exp Pathol; 2015; 8(11):15255-9. PubMed ID: 26823876
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-10 gene polymorphisms and hepatocellular carcinoma susceptibility: a meta-analysis.
Wei YG; Liu F; Li B; Chen X; Ma Y; Yan LN; Wen TF; Xu MQ; Wang WT; Yang JY
World J Gastroenterol; 2011 Sep; 17(34):3941-7. PubMed ID: 22025883
[TBL] [Abstract][Full Text] [Related]
11. Association between COX-2 gene polymorphisms and risk of hepatocellular carcinoma development: a meta-analysis.
Lu SC; Zhong JH; Tan JT; Tang HL; Liu XG; Xiang BD; Li LQ; Peng T
BMJ Open; 2015 Oct; 5(10):e008263. PubMed ID: 26438136
[TBL] [Abstract][Full Text] [Related]
12. XRCC1 genetic polymorphism Arg399Gln and hepatocellular carcinoma risk: a meta-analysis.
Liu F; Li B; Wei Y; Yan L; Wen T; Zhao J; Xu M
Liver Int; 2011 Jul; 31(6):802-9. PubMed ID: 21645210
[TBL] [Abstract][Full Text] [Related]
13. Association between rs738409 polymorphism in patatin-like phospholipase domain-containing protein 3 (PNPLA3) gene and hepatocellular carcinoma susceptibility: Evidence from case-control studies.
Li JF; Zheng EQ; Xie M
Gene; 2019 Feb; 685():143-148. PubMed ID: 30403964
[TBL] [Abstract][Full Text] [Related]
14. Five COX-2 gene polymorphisms and risk of breast cancer: an updated meta-analysis based on 19 case-control studies.
Li Q; Liu L; Liu Y; Zhou H; Yang Z; Yuan K; Min W
Med Oncol; 2015 Jan; 32(1):397. PubMed ID: 25433948
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms of tumor necrosis factor-alpha and hepatocellular carcinoma risk: a HuGE systematic review and meta-analysis.
Wei Y; Liu F; Li B; Chen X; Ma Y; Yan L; Wen T; Xu M; Wang W; Yang J
Dig Dis Sci; 2011 Aug; 56(8):2227-36. PubMed ID: 21336601
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms of C-reactive protein increase susceptibility to HBV-related hepatocellular carcinoma in a Guangxi male population.
Lao X; Ren S; Lu Y; Yang D; Qin X; Li S
Int J Clin Exp Pathol; 2015; 8(12):16055-63. PubMed ID: 26884882
[TBL] [Abstract][Full Text] [Related]
17. COX-2 rs689466, rs5275, and rs20417 polymorphisms and risk of head and neck squamous cell carcinoma: a meta-analysis of adjusted and unadjusted data.
Leng WD; Wen XJ; Kwong JSW; Huang W; Chen JG; Zeng XT
BMC Cancer; 2016 Jul; 16():457. PubMed ID: 27412115
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2 polymorphisms and bladder cancer risk: a meta-analysis based on case-control studies.
Wan GX; Chen P; Yu XJ; Di QS; Yu YD; Lei JH; Tai YY; Cao FJ
Int J Clin Exp Med; 2015; 8(3):3935-45. PubMed ID: 26064295
[TBL] [Abstract][Full Text] [Related]
19. The COX-2 rs20417 polymorphism and risk of coronary artery disease: evidence from 17,621 subjects.
Wang H; Fu Y; Liu D; Zhang M; Zhang G; Wu W; Yang S; Li C; Zhang H
Heart Lung Circ; 2014 Jun; 23(6):572-7. PubMed ID: 24513487
[TBL] [Abstract][Full Text] [Related]
20. Lack of association of EPHX1 gene polymorphisms with risk of hepatocellular carcinoma: a meta-analysis.
Duan CY; Liu MY; Li SB; Ma KS; Bie P
Tumour Biol; 2014 Jan; 35(1):659-66. PubMed ID: 23955801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
